Suppression of post-hypoxic and post-encephalitic myoclonus with levetiracetam.
about
Levetiracetam in the treatment of epilepsyAudiogenic reflex seizures in cats.Post-hypoxic Myoclonus: Current Concepts, Neurophysiology, and TreatmentLance-Adams syndrome: a report of two cases.Suppression of myoclonus in corticobasal degeneration by levetiracetamThree new drugs for epilepsy: levetiracetam, oxcarbazepine, and zonisamide.Oral pharmacotherapy of childhood movement disorders.Clinical presentations and phenomenology of myoclonus.Treatment strategies for myoclonic seizures and epilepsy syndromes with myoclonic seizures.Levetiracetam in pediatrics.Post-anoxic myoclonus: a case presentation and review of management in the rehabilitation setting.The safety of levetiracetam.Volatile anesthetic for the control of posthypoxic refractory myoclonic status.Lance-Adams Syndrome in the Pretargeted Temperature Management Era.Similarities in Mechanisms and Treatments for Epileptic and Nonepileptic Myoclonus.Levetiracetam reduces myoclonus in corticobasal degeneration: report of two cases.Levetiracetam psychosis in children with epilepsy.Suppression of cortical myoclonus by levetiracetam.Effect of levetiracetam on epileptiform discharges in human neocortical slices.Dramatic effect of levetiracetam on epileptic negative myoclonus.Brivaracetam is superior to levetiracetam in a rat model of post-hypoxic myoclonus.Successful treatment of encephalopathy and myoclonus with levetiracetam in a case of subacute sclerosing panencephalitis.Gait and Balance Dysfunction in Adults.Levetiracetam in patients with cortical myoclonus: a clinical and electrophysiological study.Clinical analysis in familial cortical myoclonic tremor allows differential diagnosis with essential tremor.Levetiracetam in the treatment of idiopathic generalized epilepsies.Levetiracetam suppresses long-loop reflexes at the cortical level.Nonepileptic Myoclonus Following Bupropion Overdose.Improvement of early diagnosed post-anoxic myoclonus with levetiracetam.
P2860
Q24656333-89B8BEF6-4CC1-40F3-A85F-5C88B281A157Q27324195-CB79E711-55AF-49B7-912D-8C8A51E7A1F7Q28066279-A3F9033E-CCF5-4751-BAA9-3B8C6B3A28F0Q31131776-7CE36479-8EE6-4E4B-8F66-DD9DE21E0C38Q33734433-BBA712E0-B3A0-48F9-AC70-5D60352F925FQ34579452-DFAA3D20-755B-4447-9EE7-DB7819F36B72Q35292308-35852B35-025A-4E49-8A40-EAA01250D056Q35594582-DE93E167-E692-46D9-A933-8831DA10F94DQ35594589-1B2BDD21-D929-4B1E-9B73-B44F297EA8CEQ36081844-F2905FF0-F60F-4099-8B7E-ACF79B8D0C71Q36371836-1048720C-CE0B-4673-ABFE-F5CB4C17B17BQ36811528-BE46C758-5756-4121-ADAA-17E54AC19B13Q37195839-E4D82A3E-4CF0-40AE-8EC7-0FAAC9276372Q38818770-F36A8B1F-0B75-4431-83D7-6994E9774AE2Q40467316-52D2BC4A-ACF6-4A17-8339-B2C70F0A21B8Q43276214-49214F7E-3941-42E9-B797-CC0E96413B7AQ43906073-CD368EA6-633E-4D1F-96F5-2AB2836CF3F5Q43938537-30498DAE-5552-4E10-B4FA-175F695C008CQ44235097-4C6EA6FE-96B1-4784-A4F4-67F4C5C04567Q44390440-33897979-5770-486B-AC26-4E75067D2A76Q46007508-00DB4473-B11A-469B-831B-C0AE32E059A6Q46158484-B684BA4C-8747-474A-B3D8-E9ACACD19731Q46480540-45054288-C7A3-48C5-974D-9C5982505544Q46632790-9C0DBD45-6350-431A-9A15-F939734C7601Q46799140-F8D9D050-6169-4F4D-8E47-F75DC369B9C5Q46816008-11FFA88E-3DFD-4D4A-A4BE-62D4D19420BAQ46976769-947D8EC5-D7FE-47BC-BEFA-85FECF3D3108Q50079678-4D6FB142-98E1-42DE-8378-0A54A0CCA33AQ53970020-E6797822-9B55-4C8A-AFFF-F005B25C6349
P2860
Suppression of post-hypoxic and post-encephalitic myoclonus with levetiracetam.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Suppression of post-hypoxic and post-encephalitic myoclonus with levetiracetam.
@ast
Suppression of post-hypoxic and post-encephalitic myoclonus with levetiracetam.
@en
type
label
Suppression of post-hypoxic and post-encephalitic myoclonus with levetiracetam.
@ast
Suppression of post-hypoxic and post-encephalitic myoclonus with levetiracetam.
@en
prefLabel
Suppression of post-hypoxic and post-encephalitic myoclonus with levetiracetam.
@ast
Suppression of post-hypoxic and post-encephalitic myoclonus with levetiracetam.
@en
P2093
P356
P1433
P1476
Suppression of post-hypoxic and post-encephalitic myoclonus with levetiracetam.
@en
P2093
P304
P356
10.1212/WNL.56.3.411
P407
P577
2001-02-01T00:00:00Z